ClinicalTrials.gg
Status unknownNCT05512884Updated Jan 19, 2023

Speeded Anomia Treatment in Chronic Post-stroke Aphasia

An interventional study of Speeded anomia therapy in Aphasia, sponsored by University of Cambridge. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-01-19.

Sponsored by University of Cambridge · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main aim of the study is to investigate the effect of a novel, speeded anomia therapy (Conroy et al., 2018) in a large population of patients with chronic post-stroke aphasia. The treatment will be delivered via a web application (QuickWord).

Read the detailed description

The main aim is to test the clinical efficacy of a novel, web based, rehabilitation approach to aphasic word-finding difficulties (QuickWord). In an initial development and case-series evaluation, Conroy et al (2018, Brain) found that training for both speed as well as accuracy of naming generated much better outcomes to picture naming accuracy and also augmented the carry-over to connected speech production.

This is a randomised, crossover, clinical trial of QuickWord in a group of aphasic patients in the chronic post-stroke period. The comparison will be standard care. The main outcome measures are clinically relevant improvement in naming to confrontation, and spontaneous use of the target vocabulary in a connected speech sample (detailed picture description). Secondary outcome includes measured use of the vocabulary in a story-telling, connected speech assessment (retelling of the Cinderella story).

02

Conditions studied

  • Aphasia

Keywords

  • Anomia
  • Speech Disorders
  • Language Disorders
  • Communication Disorders
03

In context

Aphasia

338 studies on the registry are indexed under Aphasia; 95 are open to participants now.

This study's planned enrollment of 100 is above the median of 30 across 298 interventional studies indexed under Aphasia.

Browse Aphasia studies →

Lead sponsor

University of Cambridge is the lead sponsor of 116 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Native English speakers
  • Age 18 years or above
  • Stroke (any type) greater than 12 months post onset
  • No history of neurological disorders / psychiatric disorders
  • Normal or corrected-to-normal hearing \& vision
  • Able to give
  • Currently not receiving Speech \& Language therapy
  • Minimal repetition skills (>40% on an immediate word repetition test)
  • Evidence of naming difficulties (\<90% in Boston Naming Test - Goodglass et al., 1983)

Exclusion criteria

Exclusion Criteria:

  • Non-native English speakers
  • Less than 18 years old
  • Stroke less than 12 months post onset
  • History of neurological disorders / psychiatric disorders
  • Uncorrected hearing \& vision
  • Unable to give
  • Currently receiving Speech \& Language therapy
  • Insufficient repetition skills (\<40% on an immediate word repetition test)
  • Good naming performance (>90% in Boston Naming Test - Goodglass et al., 1983)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Speeded anomia therapy

    21h of anomia therapy

    Behavioral: Speeded anomia therapy

  • No intervention
    Standard care

    Participants' typical daily routine

Interventions

  • BehavioralSpeeded anomia therapy

    The speeded anomia therapy was introduced as RISP (Repeated, Increasingly Speeded Production) by Conroy et al. (2018). Participants are asked to name the picture presented to them before an auditory stimulus ('beep' sound) at the end of item presentation. In each session the allotted response time is gradually reduced. After an incorrect response, participants are asked to repeat the word three times.

06

What researchers measure

Primary outcomes

  1. Speeded anomia therapy effect in reaction time

    Change in reaction time in single-item picture naming

    Time frame: Measured over 10 weeks (Week 0, Week 2, Week 4, Week 6, Week 10)

  2. Speeded anomia therapy effect in accuracy

    Change in accuracy in single-item picture naming

    Time frame: Measured over 10 weeks (Week 0, Week 2, Week 4, Week 6, Week 10)

  3. Generalisation to connected speech

    Change in word retrieval in composite picture description. Participants will be asked to describe composite pictures (from the "Where's Waldo/Wally?" publications).

    Time frame: Measured over 10 weeks (Week 0, Week 2, Week 4, Week 6, Week 10)

Secondary outcomes

  1. Generalisation to story-telling connected speech

    Change in narrative speech production. Participants will be asked to narrate the Cinderella story. A checklist with some of the most frequently used nouns (data obtained from AphasiaBank database) will be used.

    Time frame: Measured over 10 weeks (Week 0, Week 2, Week 4, Week 6, Week 10)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Conroy P, Sotiropoulou Drosopoulou C, Humphreys GF, Halai AD, Lambon Ralph MA. Time for a quick word? The striking benefits of training speed and accuracy of word retrieval in post-stroke aphasia. Brain. 2018 Jun 1;141(6):1815-1827. doi: 10.1093/brain/awy087. PubMed 29672757 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 19, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05512884
Responsible party
Matthew A. Lambon Ralph (Professor, University of Cambridge) — Principal investigator
First posted
Aug 23, 2022
Start date
Jan 15, 2023 (estimated)
Primary completion
Sep 1, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Jan 19, 2023

Study contacts

Eleni Zevgolatakou, MSc
Contact
Elena.Zevgolatakou@mrc-cbu.cam.ac.uk
+447724386296
Ajay Halai, PhD
Contact
Ajay.Halai@mrc-cbu.cam.ac.uk
+447508764348
Matthew Lambon Ralph, DPhil
principal investigator · MRC Cognition and Brain Sciences Unit, University of Cambridge

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion